X-100406630-A-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001184880.2(PCDH19):​c.1968T>A​(p.Ala656Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000818 in 1,209,785 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 37 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A656A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., 13 hem., cov: 23)
Exomes 𝑓: 0.000065 ( 0 hom. 24 hem. )

Consequence

PCDH19
NM_001184880.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.116

Publications

0 publications found
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PCDH19 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 9
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant X-100406630-A-T is Benign according to our data. Variant chrX-100406630-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 206300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.116 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000251 (28/111674) while in subpopulation AMR AF = 0.00227 (24/10580). AF 95% confidence interval is 0.00156. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 28 AD,XL,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH19NM_001184880.2 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 6 ENST00000373034.8 NP_001171809.1
PCDH19NM_001105243.2 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 5 NP_001098713.1
PCDH19NM_020766.3 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 5 NP_065817.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 6 1 NM_001184880.2 ENSP00000362125.4
PCDH19ENST00000255531.8 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 5 1 ENSP00000255531.7
PCDH19ENST00000420881.6 linkc.1968T>A p.Ala656Ala synonymous_variant Exon 1 of 5 1 ENSP00000400327.2
PCDH19ENST00000636150.1 linkc.-115T>A upstream_gene_variant 5 ENSP00000490463.1

Frequencies

GnomAD3 genomes
AF:
0.000251
AC:
28
AN:
111674
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00227
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000283
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000143
AC:
26
AN:
181568
AF XY:
0.0000741
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000731
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000491
Gnomad OTH exome
AF:
0.000449
GnomAD4 exome
AF:
0.0000647
AC:
71
AN:
1098111
Hom.:
0
Cov.:
31
AF XY:
0.0000660
AC XY:
24
AN XY:
363469
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26400
American (AMR)
AF:
0.000568
AC:
20
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54121
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40517
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000558
AC:
47
AN:
842048
Other (OTH)
AF:
0.0000868
AC:
4
AN:
46095
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000251
AC:
28
AN:
111674
Hom.:
0
Cov.:
23
AF XY:
0.000384
AC XY:
13
AN XY:
33836
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30635
American (AMR)
AF:
0.00227
AC:
24
AN:
10580
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.000283
AC:
1
AN:
3528
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2664
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6035
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53149
Other (OTH)
AF:
0.00
AC:
0
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000472

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 10, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Developmental and epileptic encephalopathy, 9 Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.4
DANN
Benign
0.36
PhyloP100
-0.12
PromoterAI
-0.025
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776150934; hg19: chrX-99661628; API